{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T21:45:51Z","timestamp":1783633551500,"version":"3.55.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2002,1,1]],"date-time":"2002-01-01T00:00:00Z","timestamp":1009843200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2002,1]]},"DOI":"10.1007\/bf03343960","type":"journal-article","created":{"date-parts":[[2014,4,12]],"date-time":"2014-04-12T14:22:47Z","timestamp":1397312567000},"page":"44-52","source":"Crossref","is-referenced-by-count":62,"title":["Radioiodine ablation and therapy in differentiated thyroid cancer under stimulation with recombinant human thyroid-stimulating hormone"],"prefix":"10.1007","volume":"25","author":[{"given":"G.","family":"Berg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Lindstedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Suurk\u00fcla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Jansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,3,11]]},"reference":[{"key":"BF03343960_CR1","first-page":"324","volume":"43","author":"C Reiners","year":"1999","unstructured":"Reiners C., Farahati J. 131I therapy of thyroid cancer patients. Q. J. Nucl. Med. 1999, 43: 324\u2013335.","journal-title":"Q. J. Nucl. Med."},{"key":"BF03343960_CR2","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1056\/NEJM199801293380506","volume":"338","author":"MJ Schlumberger","year":"1998","unstructured":"Schlumberger M.J. Papillary and follicular thyroid carcinoma. N. Engl. J. Med. 1998, 338: 297\u2013306.","journal-title":"N. Engl. J. Med."},{"key":"BF03343960_CR3","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1210\/jcem-50-4-734","volume":"50","author":"JM Goldman","year":"1980","unstructured":"Goldman J.M., Line B.R., Aamondt R.L., Robbins J. Influence of triiodothyronine withdrawal time on 131-I uptake post-thyroidectomy for thyroid cancer. J. Clin. Endocrinol. Metab. 1980, 50: 734\u2013739.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03343960_CR4","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1089\/thy.1997.7.613","volume":"7","author":"KH Dow","year":"1997","unstructured":"Dow K.H., Ferrell B.R., Anello C. Quality-of-life changes in patients with thyroid cancer after withdrawal of thyroid hormone therapy. Thyroid 1997, 7: 613\u2013619.","journal-title":"Thyroid"},{"key":"BF03343960_CR5","first-page":"83","volume":"3","author":"B Jarzab","year":"2000","unstructured":"Jarzab B., Handkiewicz-Junak D., Gawkowska-Suwinska M. Recombinant human TSH in the diagnosis and treatment of disseminated differentiated thyroid cancer. Nucl. Med. Rev. 2000, 3: 83\u201388.","journal-title":"Nucl. Med. Rev."},{"key":"BF03343960_CR6","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1530\/eje.0.1430557","volume":"143","author":"M Schlumberger","year":"2000","unstructured":"Schlumberger M., Ricard M., Pacini F. Clinical use of recombinant TSH in thyroid cancer patients. Eur. J. Endocrinol. 2000, 143: 557\u2013563.","journal-title":"Eur. J. Endocrinol."},{"key":"BF03343960_CR7","first-page":"1213","volume":"27","author":"KI Stajduhar","year":"2000","unstructured":"Stajduhar K.I., Neithercut J., Chu E., Pharm P., Rohde J., Sicotte A., Young K. Thyroid cancer: patients\u2019 experiences of receiving iodine-131 therapy. Oncol. Nurs. Forum 2000, 27: 1213\u20131218.","journal-title":"Oncol. Nurs. Forum"},{"key":"BF03343960_CR8","first-page":"188","volume":"78","author":"CA Meier","year":"1994","unstructured":"Meier C.A., Braverman L.E., Ebner S.A., Veronikis I., Daniels G.H., Ross D.S., Deraska D.J., Davies T.F., Valentine M., DeGroot L.J., Curran P., McEllin K., Reynolds J., Robbins J., Weintraub B.D. Diagnostic use of recombinant human thyrotropin in patients with thyroid carcinoma (Phase I\/II Study). J. Clin. Endocrinol. Metab. 1994, 78: 188\u2013196.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03343960_CR9","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1056\/NEJM199709253371304","volume":"337","author":"PW Ladenson","year":"1997","unstructured":"Ladenson P.W., Braverman L.E., Mazzaferri E.L., Brucker-Davis F., Cooper D.S., Garber J.R., Wondisford F.E., Davies T.F., DeGroot L.J., Daniels G.H., Ross D.S., Weintraub B.D. Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinoma. N. Engl. J. Med. 1997, 337: 888\u2013896.","journal-title":"N. Engl. J. Med."},{"key":"BF03343960_CR10","first-page":"3877","volume":"84","author":"BR Haugen","year":"1999","unstructured":"Haugen B.R., Pacini F., Reiners C., Schlumberger M., Ladenson P.W., Sherman S.I., Cooper D.S., Graham K.E., Braverman L.E., Skarulis M.C., Davies T.F., DeGroot L.J., Mazzaferri E.L., Daniels G.H., Ross D.S., Luster M., Samuels M.H., Becker D.V., Maxon H.R. III, Cavalieri R.R., Spencer C.A., McEllin K., Weintraub B.D., Ridgway E.C. A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer. J. Clin. Endocrinol. Metab. 1999, 84: 3877\u20133885.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03343960_CR11","first-page":"1132","volume":"33","author":"HR Maxon","year":"1992","unstructured":"Maxon H.R., Englaro E.E., Thomas S.R., Hertzberg S., Hinnefeld J.D., Chen L.S., Smith H., Cummings D., Aden M.D. Radioiodine 131 therapy for well-differentiated thyroid cancer \u2014 a quantitative radiation dosimetric approach. Outcome and validation in 85 patients. J. Nucl. Med. 1992, 33: 1132\u20131136.","journal-title":"J. Nucl. Med."},{"key":"BF03343960_CR12","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1530\/acta.0.1190373","volume":"37","author":"F Pacini","year":"1988","unstructured":"Pacini F., Mariotti S., Formica N., Elisei R., Anelli S., Capotorti E., Pinchera A. Thyroid autoantibodies in thyroid cancer: incidence and relationship with tumour outcome. Acta Endocrinol. (Copenh.) 1988, 37: 373\u2013380.","journal-title":"Acta Endocrinol. (Copenh.)"},{"key":"BF03343960_CR13","doi-asserted-by":"crossref","first-page":"282","DOI":"10.4158\/EP.4.5.282","volume":"4","author":"ML Adler","year":"1998","unstructured":"Adler M.L., Macapinlac H.A., Robbins R.J. Radioiodine treatment of thyroid cancer with the aid of recombinant human thyrotropin. Endocr. Pract. 1998, 4: 282\u2013286.","journal-title":"Endocr. Pract."},{"key":"BF03343960_CR14","first-page":"30","volume":"22","author":"P Perros","year":"1999","unstructured":"Perros P. Recombinant human thyroid-stimulating hormone (rhTSH) in the radioablation of well-differentiated thyroid cancer: Preliminary therapeutic experience. J. Endocrinol. Invest. 1999, 22: 30\u201334.","journal-title":"J. Endocrinol. Invest."},{"key":"BF03343960_CR15","first-page":"237","volume":"85","author":"P Rotman-Pikielny","year":"2000","unstructured":"Rotman-Pikielny P., Reynolds J.C., Barker W.C., Yen P.M., Skarulis M.C., Sarlis N.J. Recombinant human thyrotropin for the diagnosis and treatment of a highly functional metastatic struma ovarii. J. Clin. Endocrinol. Metab. 2000, 85: 237\u2013244.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03343960_CR16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1210\/jcem.82.1.3696","volume":"82","author":"AZ Rudavsky","year":"1998","unstructured":"Rudavsky A.Z., Freeman L.M. Treatment of scan-negative, thyroglobulin-positive metastatic thyroid cancer using radioiodine 131I and recombinant human thyroid-stimulating hormone [Clinical case seminar]. J. Clin. Endocrinol. Metab. 1998, 82: 11\u201314.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03343960_CR17","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/BF03343758","volume":"23","author":"M Luster","year":"2000","unstructured":"Luster M., Reinhardt W., Korber C., Lassmann M., Haenscheid H., Michalowski U., Rendl J., Eising E., Mann K., Reiners C. J. Endocrinol. Invest. 2000, 23: 473\u2013475.","journal-title":"J. Endocrinol. Invest."},{"key":"BF03343960_CR18","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1530\/eje.0.1440005","volume":"144","author":"F Lippi","year":"2000","unstructured":"Lippi F., Angelini F., Capezzone M., Taddei D., Pinchera A., Pacini F. Radioiodine treatment of differentiated thyroid cancer on I-thyroxine plus recombinant human TSH (rhTSH): initial single-center experience. Eur. J. Endocrinol. 2000, 144: 5\u201311.","journal-title":"Eur. J. Endocrinol."},{"key":"BF03343960_CR19","first-page":"232","volume":"37","author":"G Berg","year":"1996","unstructured":"Berg G., Michanek A., Holmberg E., Fink M. Iodine-131 treatment of hyperthyroidism: Significance of effective half-life measurements. J. Nucl. Med. 1996, 37: 232.","journal-title":"J. Nucl. Med."},{"key":"BF03343960_CR20","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/00006231-200006000-00004","volume":"21","author":"JM Durski","year":"2000","unstructured":"Durski J.M., Weigel R.J., McDougall I.R. Recombinant human thyrotropin (rhTSH) in the management of differentiated thyroid cancer. Nucl. Med. Commun. 2000, 21: 521\u2013528.","journal-title":"Nucl. Med. Commun."},{"issue":"Suppl.","key":"BF03343960_CR21","first-page":"17","volume":"22","author":"C Reiners","year":"1999","unstructured":"Reiners C., Luster M., Lassmann M. Clinical experience with recombinant human thyroid-stimulating hormone (rhTSH): Whole-body scanning with iodine-131. J. Endocrinol. Invest. 1999, 22 (Suppl.): 17\u201324.","journal-title":"J. Endocrinol. Invest."},{"key":"BF03343960_CR22","first-page":"1546","volume":"39","author":"JP Muratet","year":"1998","unstructured":"Muratet J.P., Daver A., Minier J.F., Larra F. Influence of scanning doses of iodine-131 on subsequent first ablative treatment outcome in patients operated on for differentiated thyroid carcinoma. J. Nucl. Med. 1998, 39: 1546\u20131550.","journal-title":"J. Nucl. Med."}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03343960.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03343960\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03343960","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T09:09:53Z","timestamp":1565341793000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03343960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,1]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,1]]}},"alternative-id":["BF03343960"],"URL":"https:\/\/doi.org\/10.1007\/bf03343960","relation":{},"ISSN":["0391-4097","1720-8386"],"issn-type":[{"value":"0391-4097","type":"print"},{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,1]]}}}